Rahsaan Thompson's Net Worth
$27.6 Thousand
Who is Rahsaan Thompson?
Rahsaan Thompson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gritstone Oncology, Inc., OPIANT PHARMACEUTICALS, INC., Lyell Immunopharma, Inc., and ZEVRA THERAPEUTICS, INC..
SEC CIK
Rahsaan Thompson's CIK is 0001788524
Past Insider Trading and Trends
2022 was Rahsaan Thompson's most active year for acquiring shares with 3 total transactions. Rahsaan Thompson's most active month to acquire stocks was the month of December. 2022 saw Rahsaan Thompson paying a total of $0.00 for 849,680 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gritstone Oncology, Inc. (GRTS) Snapshot price: $0.47
EVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +48.76% | 19.24K |
—
|
—
| 58.7K |
Jan 31
| |||
Form 4
| +639.58% | 25.5K |
—
|
—
| 29.49K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OPIANT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.2
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZEVRA THERAPEUTICS, INC. (ZVRA) Snapshot price: $7.26
Chief Legal & Compliance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||